Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations

Katherine L. Hoffman, Edward J. Schenck, Michael Satlin, William Whalen, Di Pan, Nicholas Williams, Iván Díaz
doi: https://doi.org/10.1101/2022.05.27.22275037
Katherine L. Hoffman
1Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kah2797@med.cornell.edu
Edward J. Schenck
2Division of Pulmonary and Critical Care, Department of Medicine, Weill Cornell Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Satlin
3Division of Infectious Disease, Department of Medicine, Weill Cornell Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Whalen
2Division of Pulmonary and Critical Care, Department of Medicine, Weill Cornell Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Di Pan
2Division of Pulmonary and Critical Care, Department of Medicine, Weill Cornell Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Williams
4Department of Epidemiology, Mailman School of Public Health, Columbia University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iván Díaz
1Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Observational research provides a unique opportunity to learn causal effects when randomized trials are not available, but obtaining the correct estimates hinges on a multitude of design and analysis choices. We illustrate the advantages of modern causal inference methods and compare to standard research practice to estimate the effect of corticosteroids on mortality in hospitalized COVID-19 patients in an observational dataset. We use several large randomized controlled trials (RCTs) to benchmark our results.

Methods Our retrospective data source consists of 3,293 COVID-19 patients hospitalized at New York Presbyterian March 1-May 15, 2020. We design our study using the Target Trial Emulation framework. We estimate the effect of an intervention consisting of 6 days of corticosteroids administered at the time of severe hypoxia and contrast with an intervention consisting of no corticosteroids administration. The dataset includes dozens of time-varying confounders. We estimate the causal effects using a doubly robust estimator where the probabilities of treatment, outcome, and censoring are estimated using flexible regressions via super learning. We compare these analyses to standard practice in clinical research, consisting of two main methods: (i) Cox models for an exposure of corticosteroids receipt within various time windows of hypoxia, and (ii) a Cox time-varying model where the exposure is daily administration of corticosteroids starting at the time of hospitalization.

Results The effect in our target trial emulation is qualitatively identical to an RCT benchmark, estimated to reduce 28-day mortality from 32% (95% confidence interval: 31-34) to 23% (21-24). The estimated effect from meta-analyses of RCTs for corticosteroids is an odds ratio of 0.66 (0.53-0.82). Hazard ratios from the Cox models range in size and direction from 0.50 (0.41-0.62) to 1.08 (0.80-1.47) and all study designs suffer from various forms of bias.

Conclusion We demonstrate that clinical research based on observational data can unveil true causal relations. However, the correctness of these effect estimates requires designing and analyzing the data based on principles which are different from the current standard in clinical research. The widespread communication and adoption of these design and analytical techniques is of high importance for the improvement of clinical research based on observational data.

Competing Interest Statement

Dr. Edward Schenck is supported by NHLBI HL151876 and reports consulting for Axle Informatics regarding Coronavirus vaccine clinical trial through NIAID outside of the current work. Dr. Michael Satlin is supported by research grants from Allergan, Merck, BioFire Diagnostics, and SNIPRBiome. He reports consulting payments from Shionogi.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Review Board at Weill Cornell Medicine with a waiver of informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data produced in the present study are available in HIPAA compliant de-identified form upon reasonable request to the authors.

https://github.com/kathoffman/steroids-trial-emulation

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 29, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations
Katherine L. Hoffman, Edward J. Schenck, Michael Satlin, William Whalen, Di Pan, Nicholas Williams, Iván Díaz
medRxiv 2022.05.27.22275037; doi: https://doi.org/10.1101/2022.05.27.22275037
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations
Katherine L. Hoffman, Edward J. Schenck, Michael Satlin, William Whalen, Di Pan, Nicholas Williams, Iván Díaz
medRxiv 2022.05.27.22275037; doi: https://doi.org/10.1101/2022.05.27.22275037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Intensive Care and Critical Care Medicine
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (433)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (420)
  • Epidemiology (8982)
  • Forensic Medicine (4)
  • Gastroenterology (419)
  • Genetic and Genomic Medicine (1949)
  • Geriatric Medicine (190)
  • Health Economics (401)
  • Health Informatics (1328)
  • Health Policy (659)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10800)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1825)
  • Nursing (109)
  • Nutrition (272)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (997)
  • Ophthalmology (297)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (579)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1896)
  • Public and Global Health (4120)
  • Radiology and Imaging (675)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (80)